Lu Hua Holding Group Co., Ltd. Lu Hua Group

Formerly known as Lu Hua Co., Ltd., the company was incorporated in Hong Kong in June 2006 at 1985. It is the first wholly-owned company established by Shandong Province overseas, and it is a window company for Shandong Province to carry out economic and trade activities in Hong Kong. June 5438+October 2005 10, Lu Hua Holding Group Co., Ltd. was incorporated in China with the approval of Shandong Provincial State-owned Assets Supervision and Administration Commission, and the parent-subsidiary company management system was implemented. In July, 2006, according to the strategic deployment of building a number of large enterprise groups determined by the provincial party committee and government, Kang Group was transferred to the group as a whole. After the transfer, Lu Hua Group has become an important backbone enterprise in Shandong pharmaceutical and chemical industry.

Since its establishment, the company has insisted on increasing its strength by capital operation and vitality by reform management, and successfully realized the transformation from a trading company to a comprehensive operation group company, and developed into a large enterprise group with coal chemical industry and medicine as its main business and involved in international trade, real estate and other fields. It owns five wholly-owned subsidiaries: Lu Hua Group, Shandong Lu Hua Group, Shandong Lu Hua Hang Seng Group, Shandong Xinhua Pharmaceutical Group and Shandong Lu Kang Pharmaceutical Group. It holds three listed companies: Shandong Lu Hua Hengsheng Chemical Co., Ltd. (code 600426), Shandong Xinhua Pharmaceutical Co., Ltd. (H-share code 07 19, A-share code 000756) and Shandong Lu Kang Pharmaceutical Co., Ltd. (stock code 600789), with employees160,000 and total assets exceeding 20 billion yuan.

It has the world's largest producer of DMF (dimethylformamide), the largest production base of antipyretic and analgesic drugs in Asia, and an important production base of nitrogen fertilizer, cardiovascular and cerebrovascular drugs, antibiotics and biopharmaceuticals in China. It has/kloc-0 national technical centers, 2 provincial technical centers and 2 postdoctoral research centers, and has more than 200 national patents. A number of innovative achievements have won the National Management Modernization Innovation Achievement Award and the Industry Science and Technology Progress Award. Among them, the first domestic technical transformation demonstration project of a large-scale nitrogenous fertilizer plant won the National Development and Reform Commission's important contribution award for revitalizing the equipment manufacturing industry, the China Petrochemical Association's special prize for scientific and technological progress, and the "300,000 tons of complete ammonia technology and key equipment development and application" project won the second prize of national scientific and technological progress in 2008.